Androgens and AR stimulate oncogenic Wnt and HER2 signaling pathways in ER−/HER2+ breast cancer, which indicates an intrinsic link between AR and growth factor pathways in ER-negative breast cancer12. This evidence concerns the gene ERBB2 and breast cancer.